Press release

New essential Orange and Green Guides 2015 – out now!

Latest UK pharmaceutical regulations, EU directives and guidance for manufacturers and distributors of human medicines available to buy now.

The latest UK pharmaceutical regulations, EU directives and guidance for manufacturers and distributors of human medicines, known as the Orange and Green Guides, compiled by the Medicines and Healthcare products Regulatory Agency (MHRA), are available to buy now. These are an essential purchase for anyone subject to good manufacturing practice (GMP) and good distribution practice (GDP) in Europe.

The Orange Guide (Rules and Guidance for Pharmaceutical Manufacturers and Distributors) contains information and legislation relating to the manufacture and distribution of human medicines. The Green Guide (Rules and Guidance for Pharmaceutical Distributors) provides information on the broader distribution.

Mark Birse, MHRA GMDP Group Manager, IE&S said:

The Orange and Green Guides are essential tools in helping companies understand the regulatory environment in which they operate, follow good practice and stay compliant with the law.

This is key to ensuring that safe and high quality medicines for people are being made and distributed, providing the trust needed by patients and healthcare professionals to use them.

The new 2015 edition of the Orange Guide includes changes made to European Community guidelines on GMP and the revised EU Guidelines on GDP.

There are new sections on:

  • MHRA Innovation Office
  • MHRA Compliance Management and Inspection Action Group
  • MHRA’s risk-based inspection programme naming Contract Quality Control laboratories on a manufacturer’s licence
  • the gold standard for Responsible Persons
  • the application and inspection process for new licences - what to expect

The new Green Guide has been updated to incorporate the revised EU Guidelines on GDP. In addition there are new sections on:

  • GDP quality systems
  • the European Commission Q&A on GDP guidelines
  • the Gold Standard for Responsible Persons
  • a list of persons who can be supplied with medicines by way of wholesale dealing (Human Medicines Regulations 2012)
  • controls on certain medicinal products
  • Compliance Management and Inspection Action Group
  • the application and inspection process for new licences - what to expect
  • sales representative samples
  • handling returns of non-defective medicinal products
  • MHRA’s risk-based inspection programme
  • reporting adverse reactions
  • short-term storage of ambient and refrigerated medicinal products – requirements for a wholesale Dealers Authorisation
  • MHRA Innovation Office

Both publications provide a new flow chart on registration requirements for UK companies involved in the sourcing and supply of active substances (ASs) to be used in the manufacture of licensed human medicines.

Background

The Orange and Green Guides are published by Pharmaceutical Press, and are available to order in print at www.pharmpress.com. They are also both available online via MedicinesComplete.

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society. We produce the most comprehensive and trustworthy range of independent pharmaceutical information in the world, including reference works, textbooks, digital products and services, professional titles and journals.

The MHRA Innovation Office

MHRA is a centre of the Medicines and Healthcare Products Regulatory Agency which also includes the National Institute for Biological Standards and Control (NIBSC) and the Clinical Practice Research Datalink (CPRD). MHRA is an executive agency of the Department of Health.

Media enquiries

News centre
MHRA
151 Buckingham Palace Road
Victoria

London
SW1W 9SZ

Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhrapress